drugset / Trial / NCT00959569

Esmolol in Cardiac Surgery

NCT00959569

Phase 4 Completed 200 enrolled Vita-Salute San Raffaele University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This large randomized double-blind clinical trial (esmolol vs placebo) will enroll patients undergoing cardiac surgery to study the additive cardiac protection of this therapeutic strategy.

Timeline

Start
2009-08
Primary completion
2018-05
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmolol Other / unclassified 1 mg/kg
Subject Esmolol Other / unclassified 3 mg/kg